Exhibit 10.1 QUICK-MED TECHNOLOGIES, INC. LICENSE AGREEMENT License Agreement dated September 13 , 2000 by and among Quick Med Technologies, Inc., a Delaware corporation ("QMT") and Richard Galardy and Damian Grobelny (the "INVENTORS"). WHEREAS, the...License Agreement • July 13th, 2001 • Above Average Investments LTD • Non-operating establishments • New York
Appendix A WORK PRODUCT FOR DR. WILLIAM TOREKI UNDER CONSULTING AGREEMENT WITH QUICK MED TECHNOLOGIESConsulting Agreement • January 8th, 2002 • Above Average Investments LTD • Non-operating establishments
AGREEMENT AND PLAN OF REORGANIZATIONAgreement and Plan of Reorganization • April 10th, 2001 • Above Average Investments LTD • Non-operating establishments • Nevada
EX-10.1.1Agreement And • July 18th, 2001 • Above Average Investments LTD • Non-operating establishments
AGREEMENT AND PLAN OF REORGANIZATIONAgreement and Plan of Reorganization • February 26th, 2002 • Above Average Investments LTD • Non-operating establishments • Nevada
Exhibit 10.3 A COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTCooperative Research and Development Agreement • January 8th, 2002 • Above Average Investments LTD • Non-operating establishments
QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTEQuick Med Technologies Inc • October 5th, 2007 • Surgical & medical instruments & apparatus • Florida
FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Phronesis Partners, L.P., its successors or assigns (the “Lender”) at the Lender’s office at 180 East Broad St. #1704, Columbus, Ohio 43215, or at such other place as the Lender may from time to time designate, the principal amount of three hundred seventy five thousand dollars ($375,000.00) (the “Principal Amount”) as is disbursed to Borrower pursuant to this Note, together with interest on the unpaid Principal Amount outstanding from time to time at the rate or rates hereafter specified and any and all other sums which may be owing to the Lender by the Borrower pursuant to this Note. The Borrower acknowledges it has already received proceeds of ONE HUNDRED TWENTY FIVE THOUSAND DOLLARS ($125,000) from Lender and that therefore this is the current Principal Amount as of the date of this Note. The following terms shall apply to this Promissory Note:
10. Entire Agreement. This Agreement contains all of the understandings and agreements of the parties with respect to the subject matter discussed herein. All prior agreements, whether written or oral, are merged herein and shall be of no force or...Consulting Agreement • January 8th, 2002 • Above Average Investments LTD • Non-operating establishments • Florida
PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • April 2nd, 2007 • Quick Med Technologies Inc • Surgical & medical instruments & apparatus • Florida
This Patent and Technology License Agreement (“Agreement”), effective this 23 day of March 2007 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Delaware corporation having offices at 3427 SW 42nd Way, Gainesville, Florida 32608 (“QMT”) and Derma Sciences, Inc., a Pennsylvania corporation having offices at 214 Carnegie Center, Suite 100, Princeton, New Jersey 08540 (“DERMA”) (each singularly a “Party” and collectively the “Parties”).
LICENSE AGREEMENTLicense Agreement • October 5th, 2007 • Quick Med Technologies Inc • Surgical & medical instruments & apparatus • Michigan
This Agreement is effective as of May 24, 2007 (the "Effective Date"), between Quick-Med Technologies, Inc. ("LICENSEE") having the address in Article 13 below, and the Regents of the University of Michigan, a constitutional corporation of the State of Michigan ("MICHIGAN"). LICENSEE and MICHIGAN agree as follows:
JOINT DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENTJoint Development and Exclusive Option Agreement • October 14th, 2009 • Quick Med Technologies Inc • Surgical & medical instruments & apparatus • Ohio
This Joint Development and Exclusive Option Agreement (“Agreement”), effective as of the date signed by both parties (“Effective Date”), is entered into by and between
PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • June 28th, 2012 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • Florida
This Patent and Technology License Agreement (“Agreement”), effective this 1st day of October 2011 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW Fourth Street, Gainesville, Florida 32601 (“QMT”) and Biosara Corporation., a Delaware corporation having offices at 103 Costa Bella Cove, Austin, Texas 78734 (“BIOSARA”) (each singularly a “Party” and collectively the “Parties”).
PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • July 18th, 2012 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • Delaware
This Patent and Technology License Agreement (“Agreement”), effective as of the 12th day of July, 2012 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW 4 Street, Gainesville, Florida 32601 (“QMT”) and Derma Sciences, Inc., a Pennsylvania corporation having offices at 214 Carnegie Center, Suite 300, Princeton, New Jersey 08540 (“DERMA”) (each singularly a “Party” and collectively the “Parties”).
Exhibit 10.8 ------------ MASTER AGREEMENT BETWEEN COLLABORATIVE AND QMT FOR PRODUCT DEVELOPMENT, MANUFACTURING AND DISTRIBUTION This Master Agreement for Product Development, Manufacturing and Distribution (the "Agreement") is made on this 15th day...Master Agreement • October 15th, 2002 • Quick Med Technologies Inc • Non-operating establishments • New York
Exhibit 10.9 Terms for a Distribution Agreement Between Noville and Quick-Med Technologies, Inc.Quick Med Technologies Inc • November 19th, 2003 • Pharmaceutical preparations
PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • July 30th, 2010 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • Florida
This Patent and Technology License Agreement (“Agreement”), effective this 26th day of July 2010 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW Fourth Street, Gainesville, Florida 32601 (“QMT”) and Viridis BioPharma Pvt. Ltd., an India corporation having offices at 6/10, Jogani Industrial Complex, V.N. Purav Marg, Chunabhatti, Mumbai – 400022, India (“VIRIDIS”) (each singularly a “Party” and collectively the “Parties”).
FOURTH AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of June 30th, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
CONFIDENTIALITY AND NONDISCLOSURE AGREEMENTConfidentiality and Nondisclosure Agreement • December 3rd, 2004 • Quick Med Technologies Inc • Pharmaceutical preparations • Florida
THIS CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT (the “Agreement”) is made and entered into as of November 30, 2004, by and between QUICK-MED TECHNOLOGIES, INC., a Nevada corporation (the “Disclosing Party” or the “Company”), and PHRONESIS PARTNERS, L.P., a Delaware limited partnership ( the “Receiving Party”).
STOCKHOLDERS AGREEMENTStockholders Agreement • December 3rd, 2004 • Quick Med Technologies Inc • Pharmaceutical preparations • Nevada
THIS STOCKHOLDERS AGREEMENT (this “Agreement”) is made and entered into as of November 30, 2004, by and among QUICK-MED TECHNOLOGIES, INC., a Nevada corporation (the “Company”), PHRONESIS PARTNERS, L.P., a Delaware limited partnership (“Phronesis”), MICHAEL R. GRANITO, an individual (“Granito”), and DAVID S. LERNER, an individual (“Lerner”). Phronesis, Granito and Lerner, and each of the other equity holders (if any) listed on the Schedule of Stockholders attached hereto (each, an “Additional Stockholder” and together with Phronesis, Granito and Lerner, the “Stockholders”). Capitalized terms used herein are defined in §1 hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 3rd, 2004 • Quick Med Technologies Inc • Pharmaceutical preparations • Nevada
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 30, 2004, by and among QUICK-MED TECHNOLOGIES, INC., a Nevada corporation (the “Company”), PHRONESIS PARTNERS, L.P., a Delaware limited partnership (“Phronesis”), MICHAEL R. GRANITO, an individual (“Granito”), and DAVID S. LERNER, an individual (“Lerner” and together with Granito, the “Management Stockholders”). Capitalized terms used but not otherwise defined herein have the meanings set forth in Section 8 hereof.
LADD GREENO EMPLOYMENT AGREEMENTEquity Award Grant Agreement • August 10th, 2007 • Quick Med Technologies Inc • Surgical & medical instruments & apparatus • Massachusetts
This Employment Agreement (the “Agreement”) is entered into as of August 6, 2007 (the “Effective Date”) by and between Quick-Med Technologies, Inc. (the “Company”) and J. Ladd Greeno (“Executive”).
LETTER OF INTENTLetter of Intent • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
This Letter of Intent is effective this 1st day of February, 2006, by and between Englehard Long Island Inc. with a registered office at 50 Health Sciences Drive, Stony Brook, NY 11790 (“Licensee”) and Quick Med Technologies, Inc., with a registered office at 3427 SW 42nd Way, Gainesville, Florida 32608 (“Licensor”), relating to the possible licensing of Licensor’s proprietary matrix metalloproteinase inhibitor referred to as Ilomastat and defined as the “Licensed Compound” on Appendix A attached hereto (the “Term Sheet”). Certain capitalized terms not defined herein shall have the meanings ascribed to them in the Term Sheet.
DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENTDevelopment and Exclusive Option Agreement • February 9th, 2007 • Quick Med Technologies Inc • Surgical & medical instruments & apparatus • Florida
This Development and Exclusive Option Agreement (this “Agreement”), effective as of February 1st, 2007 (the “Effective Date”) is entered into by and between HANESBRANDS INC., having an address and contact person at 1000 East Hanes Mill Road, Winston-Salem, North Carolina 27105 (Attention: Mike Abbott) (“HBI”) and QUICK-MED TECHNOLOGIES, INC., having an address and contact person at 3427 SW 42nd Way, Gainesville, Florida 32608 (Attention: David Lerner, President) (“Quick-Med”). HBI and Quick-Med are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AND OPTION AGREEMENTDevelopment and Option Agreement • August 12th, 2010 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • Florida
This Development and Option Agreement (“Agreement”) is entered into as of August 6, 2010 (“Effective Date”) by and between Biosara Corporation, a Delaware corporation, with a principal place of business in Corinth, Texas (“Biosara”) and Quick-Med Technologies, Inc., a Nevada corporation, having its principal office at 902 NW 4th Street, Gainesville, Florida 32601 (hereinafter referred to as “Quick-Med”).
DEVELOPMENT AGREEMENTDevelopment Agreement • April 8th, 2010 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • Texas
THIS DEVELOPMENT AGREEMENT (this “Agreement”) is made effective as of the 18th day of March, 2010 (the “Effective Date”), by and between KCI USA, Inc., a Delaware corporation (“KCI”) and Quick-Med Technologies, Inc., a Nevada corporation (“Quick-Med”).
FIRST AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of April 26, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
JOINT DEVELOPMENT AGREEMENTJoint Development Agreement • April 9th, 2008 • Quick Med Technologies Inc • Surgical & medical instruments & apparatus • New York
This Joint Development Agreement (“JDA”) is entered into as of March 19, 2008 (“Effective Date”) by and between Molnlycke Health Care AB, a corporation incorporated under the laws of Sweden, with a principal place of business in Gothenburg, Sweden (“MHC”) and Quick-Med Technologies, Inc., a Nevada corporation, having its principal office at 902 NW 4th Street, Gainesville, Florida 32601 (hereinafter referred to as “QMT”).
Exhibit 10.4 November 26, 2001 Michael R. Granito Chairman Quick-Med Technologies, Inc. 401 N.E. 25 Terrace Boca Raton, Florida 33431 RE: EAC/QMT Interim Financing Agreement Dear Michael: Further to our verbal confirmation of the interim financing...Above Average Investments LTD • January 8th, 2002 • Non-operating establishments
STOCK PURCHASE AGREEMENT By and Between QUICK-MED TECHNOLOGIES, INC. and PHRONESIS PARTNERS, LP Dated as of November 30, 2004Stock Purchase Agreement • December 3rd, 2004 • Quick Med Technologies Inc • Pharmaceutical preparations • Nevada
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of November 30, 2004, is made and entered into by and between QUICK-MED TECHNOLOGIES, INC., a Nevada corporation (the “Company”), and PHRONESIS PARTNERS, L.P., a Delaware limited partnership (the “Purchaser”). The Company and the Purchaser are hereinafter referred to collectively as the “Parties” and individually as a “Party.” Except as otherwise indicated herein, terms in bolded italics used in this Agreement are defined in attached Appendix A hereto.
FORM OF LOCK-UP AGREEMENT Board of Directors ABOVE AVERAGE INVESTMENTS, LTD. Gentlemen: The undersigned, a beneficial owner of the common stock of ABOVE AVERAGE INVESTMENTS, LTD. (the "Company"), $0.0001 par value per share (the "Common Stock"),...Above Average Investments LTD • October 4th, 1999
The undersigned, a beneficial owner of the common stock of ABOVE AVERAGE INVESTMENTS, LTD. (the "Company"), $0.0001 par value per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form 10-SB (File No. ) (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company successfully implements its business plan as described in the Registration Statement.
EX - 10.1.1Agreement And • February 26th, 2002 • Above Average Investments LTD • Non-operating establishments
LICENSE AGREEMENTLicense Agreement • April 7th, 2011 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • Ohio
This LICENSE AGREEMENT (“Agreement”) is entered into and made effective April 1, 2011 (“Effective Date”) by and between Quick-Med Technologies, Inc., a Nevada corporation, having a business address of 902 NW Fourth Street, Gainesville, Florida 32601 (“Quick-Med”), and Avery Dennison Corporation, a Delaware corporation, acting through its Medical Solutions Division and having a business address of 20 North Wacker Drive, Suite 2240, Chicago, IL 60606 (“Avery”). Avery and Quick-Med are collectively and interchangeably referred to as a “Party” or the “Parties.”
LICENSE AGREEMENT by and between: Johnson & Johnson Consumer and Personal Products Worldwide, a division of Johnson & Johnson Consumer Companies, Inc. Skillman, New Jersey and Quick-Med Technologies, Inc. Gainesville, FloridaLicense Agreement • March 11th, 2010 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus • New York
WHEREAS, Johnson & Johnson Consumer and Personal Products Worldwide, a division of Johnson & Johnson Consumer Companies, Inc. (hereinafter "JJCPWW") has an established business and intellectual property relating to wound *****;
THIRD AMENDMENT TO LETTER OF INTENTLetter Of • August 11th, 2006 • Quick Med Technologies Inc • Pharmaceutical preparations
It is hereby agreed as of June 13, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that:
AWARD/CONTRACT 1. THIS CONTRACT IS A RATED ORDER RATING PAGE OF PAGES UNDER DP AS (15 CFR 700) 1 | 27 CODE 3EE54 FACILITY CODE SHOWN IN:Clauses Incorporated By • May 29th, 2013 • Quick-Med Technologies Inc • Surgical & medical instruments & apparatus
TERM/SCOPE of CONTRACT: Phase I : 15 May 2013 - 15 December 2013 (Research ends 15 November 2013). The final 30 days for submission of the final report. The scope of this contract encompasses the complete STTR process to include all Phases of the Award. Therefore, the term of this contact is for up to five (5) years unless otherwise ending sooner.
